SummaryRMgm-5319
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 37704606 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Zeeshan M, Tewari R |
Name Group/Department | School of Life Sciences |
Name Institute | University of Nottingham |
City | Nottingham |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5319 |
Principal name | EB1-GFP |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | EB1-GFP showed during male gamete formation a spatiotemporal distribution with distinct foci and elongated spindle ‘bridges’ at certain time points after gametocyte activation (see also information below). |
Fertilization and ookinete | Live cell imaging of EB1-GFP during early meiosis located the protein on spindles and spindle poles, but it then disappeared as the ookinete matured. There was also an accumulation of EB1-GFP at the nascent apical end of the developing ookinete. In later stages of ookinete differentiation, it was distributed around the periphery of the growing protuberance, potentially associated with sub-pellicular MTs but had disappeared in mature ookinetes |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Analysis of a mutant lacking expression of EB1 (RMgm-5318) showed the following: Significantly reduced oocyst numbers on day-10 post-infection of mosquitoes. The oocysts that were present were smaller than those of WT parasites, and by day-21 no oocysts were detectable. Additional information In the paper evidence is presented for a unique scaffold of an aurora-related kinase (ARK2; PBANKA_0407400; PF3D7_0309200; serine/threonine protein kinase ARK2, putative) at the spindle including the microtubule plus end-binding protein EB1, lacking conserved Aurora scaffold proteins. Gene function studies indicate complementary functions of ARK2 and EB1 in driving endomitotic divisions and thereby parasite transmission. |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0405600 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0307300 | ||||||||||||||||||||||||||
Gene product | end-binding protein 1 | ||||||||||||||||||||||||||
Gene product: Alternative name | EB1 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | unknown | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | To generate the GFP-tag line, a region of the eb1 gene downstream of the ATG start codon was amplified, ligated to p277 vector, and transfected. The p277 vector contains the human dhfr cassette, conveying resistance to pyrimethamine. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |